source
- Combination of danvatirsen and pembrolizumab fails to boost response in first-line metastatic head-and-neck cancerThe phase II PEMDA-HN trial evaluated adding the STAT3 antisense oligonucleotide danvatirsen to pembrolizumab in patients with untreated recurrent or metastatic head and neck squamous cell carcinom…
- Aging scientific workforce grapples with rising fabricated citations as hantavirus cruise ship outbreak drags onA new analysis highlights that an increasingly senior scientific workforce is coinciding with a surge in fabricated citations across medical journals, raising concerns about research integrity. Th…